Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · IEX Real-Time Price · USD
0.564
+0.019 (3.52%)
At close: May 31, 2024, 4:00 PM
0.563
-0.001 (-0.21%)
After-hours: May 31, 2024, 7:09 PM EDT

Sangamo Therapeutics Market Cap

Sangamo Therapeutics has a market cap or net worth of $117.12 million as of May 31, 2024. Its market cap has decreased by -52.33% in one year.

Market Cap
117.12M
Enterprise Value
92.60M
1-Year Change
-52.33%
Ranking
Category
Stock Price
$0.56

Market Cap Chart

Since April 6, 2000, Sangamo Therapeutics's market cap has decreased from $314.10M to $117.12M, a decrease of -62.71%. That is a compound annual growth rate of -4.00%.

History

DateMarket Cap% Change
May 31, 2024117.00M3.45%
May 30, 2024113.10M-5.04%
May 29, 2024119.10M-7.60%
May 28, 2024128.90M4.37%
May 24, 2024123.50M-3.67%
May 23, 2024128.20M-2.88%
May 22, 2024132.00M6.54%
May 21, 2024123.90M-2.90%
May 20, 2024127.60M-5.41%
May 17, 2024134.90M6.72%
May 16, 2024126.40M4.98%
May 15, 2024120.40M2.12%
May 14, 2024117.90M3.15%
May 13, 2024114.30M-1.80%
May 10, 2024116.40M7.28%
May 9, 2024108.50M20.82%
May 8, 202489.80M-7.04%
May 7, 202496.60M2.66%
May 6, 202494.10M-5.43%
May 3, 202499.50M6.53%
May 2, 202493.40M-4.01%
May 1, 202497.30M5.65%
Apr 30, 202492.10M-1.39%
Apr 29, 202493.40M0.76%
Apr 26, 202492.70M3.00%
View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Vigil Neuroscience 119.52M
Molecular Partners AG 119.46M
aTyr Pharma 119.39M
FibroGen 119.37M
Adicet Bio 119.15M
Amylyx Pharmaceuticals 116.97M
Seer, Inc. 116.89M
Karyopharm Therapeutics 114.07M
Market Cap Rankings